Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Kempharm Inc

(NASDAQ: KMPH)
Add to Portfolio
-0.02 (-5.13%)
as of Dec 13, 2019

Last 0.37
Change -0.02 (-5.13%)
Open 0.39
Prev. Close 0.39
Today's Range
0.37
0.41
52wk Range
0.33
2.85
Volume 100,800
Avg Volume 223,255
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
KMPH -5.13% -45.09% -85.12%
DJIA +0.01% +7.38% +14.38%
S&P 500 +0.01% +8.87% +19.55%

Key Statistics

Annual EPS -0.93
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 12,960
Weighted Alpha -85.19
Standard Deviation -0.72
Profit Margin N/A
Beta 1.31

Growth Rates

YTD -79.02%
1-Year -83.97%
3-Year -88.85%

Opinion

Sell Hold Buy

Recent Headlines

KemPharm Reports Third Quarter 2019 Results

GlobeNewswire via COMTEX - Thu Nov 14, 04:55PM EST
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today, November 14, 2019, at 5:30 p.m. ET(full story)
KMPH: 0.37 (-0.02)

KemPharm to Report Third Quarter 2019 Results

GlobeNewswire via COMTEX - Tue Nov 12, 08:30AM EST
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for(full story)
KMPH: 0.37 (-0.02)

KemPharm Reports APADAZ(R) Will be Available

GlobeNewswire via COMTEX - Thu Oct 31, 08:30AM EDT
KVK-Tech is Initially Stocking Selected Regions Based on Formulary Access(full story)
KMPH: 0.37 (-0.02)

KemPharm Presents Study Highlighting Patient-Friendly

GlobeNewswire via COMTEX - Tue Oct 22, 04:15PM EDT
Data Demonstrate that KP415 Can Be Administered without Regard to Food; Can Be Mixed into Foods or Drink(full story)
PTCI: 0.5500 (+0.1500), KMPH: 0.37 (-0.02)

KemPharm Provides Updates Regarding its Board of

GlobeNewswire via COMTEX - Fri Sep 20, 05:00PM EDT
KemPharm, Inc. (Nasdaq: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that, on September 18, 2019, Danny L. Thompson provided notice of his resignation (full story)
KMPH: 0.37 (-0.02)